Fighting the force: Potential of homeobox genes for tumor microenvironment regulation

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1855, Issue 2, 2015, Pages 248-253

  Northcott, Josette M ^a   Northey, Jason J ^a   Barnes, J Matthew ^a   Weaver, Valerie M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extracellular matrix; Homeobox genes; Stiffness; Stromal cells; Tumor microenvironment

Indexed keywords

CANCER ASSOCIATED FIBROBLAST; CANCER PROGNOSIS; CANCER THERAPY; EXTRACELLULAR MATRIX; FIBROBLAST; GENE; GENE EXPRESSION; HOMEOBOX GENE; HUMAN; IMMUNOCOMPETENT CELL; MECHANOTRANSDUCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RIGIDITY; STROMA CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; BIOSYNTHESIS; CARCINOGENESIS; GENE EXPRESSION REGULATION; GENETICS; NEOPLASM; PATHOLOGY;

HOMEODOMAIN PROTEIN;

CARCINOGENESIS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASMS; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84961291159     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2015.03.004     Document Type: Review

References (60)

1. Butcher D.T., Alliston T., Weaver V.M. A tense situation: forcing tumour progression, Nature reviews. Cancer 2009, 9:108-122.
2. Hamill O.P., Martinac B. Molecular basis of mechanotransduction in living cells. Physiol. Rev. 2001, 81:685-740.
3. Barcellos-Hoff M.H., Aggeler J., Ram T.G., Bissell M.J. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 1989, 105:223-235.
4. Weaver V.M., Petersen O.W., Wang F., Larabell C.A., Briand P., Damsky C., Bissell M.J. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 1997, 137:231-245.
5. Paszek M.J., Zahir N., Johnson K.R., Lakins J.N., Rozenberg G.I., Gefen A., Reinhart-King C.A., Margulies S.S., Dembo M., Boettiger D., Hammer D.A., Weaver V.M. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005, 8:241-254.
6. Samuel M.S., Lopez J.I., McGhee E.J., Croft D.R., Strachan D., Timpson P., Munro J., Schroder E., Zhou J., Brunton V.G., Barker N., Clevers H., Sansom O.J., Anderson K.I., Weaver V.M., Olson M.F. Actomyosin-mediated cellular tension drives increased tissue stiffness and beta-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011, 19:776-791.
7. Levental K.R., Yu H., Kass L., Lakins J.N., Egeblad M., Erler J.T., Fong S.F., Csiszar K., Giaccia A., Weninger W., Yamauchi M., Gasser D.L., Weaver V.M. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
8. Pickup M.W., Mouw J.K., Weaver V.M. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014, 15:1243-1253.
9. Wozniak M.A., Desai R., Solski P.A., Der C.J., Keely P.J. ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J. Cell Biol. 2003, 163:583-595.
10. Mouw J.K., Yui Y., Damiano L., Bainer R.O., Lakins J.N., Acerbi I., Ou G., Wijekoon A.C., Levental K.R., Gilbert P.M., Hwang E.S., Chen Y.Y., Weaver V.M. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat. Med. 2014, 20:360-367.
11. Chung A.S., Lee J., Ferrara N. Targeting the tumour vasculature: insights from physiological angiogenesis, Nature reviews. Cancer 2010, 10:505-514.
12. Weis S.M., Cheresh D.A. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med. 2011, 17:1359-1370.
13. Lu K.V., Chang J.P., Parachoniak C.A., Pandika M.M., Aghi M.K., Meyronet D., Isachenko N., Fouse S.D., Phillips J.J., Cheresh D.A., Park M., Bergers G. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 2012, 22:21-35.
14. Ghajar C.M., Peinado H., Mori H., Matei I.R., Evason K.J., Brazier H., Almeida D., Koller A., Hajjar K.A., Stainier D.Y., Chen E.I., Lyden D., Bissell M.J. The perivascular niche regulates breast tumour dormancy. Nat. Cell Biol. 2013, 15:807-817.
15. Lee P.F., Bai Y., Smith R.L., Bayless K.J., Yeh A.T. Angiogenic responses are enhanced in mechanically and microscopically characterized, microbial transglutaminase crosslinked collagen matrices with increased stiffness. Acta Biomater. 2013, 9:7178-7190.
16. Liu J., Agarwal S. Mechanical signals activate vascular endothelial growth factor receptor-2 to upregulate endothelial cell proliferation during inflammation. J. Immunol. 2010, 185:1215-1221.
17. Underwood C.J., Edgar L.T., Hoying J.B., Weiss J.A. Cell-generated traction forces and the resulting matrix deformation modulate microvascular alignment and growth during angiogenesis, American journal of physiology. Heart Circ. Physiol. 2014, 307:H152-H164.
18. Mammoto A., Connor K.M., Mammoto T., Yung C.W., Huh D., Aderman C.M., Mostoslavsky G., Smith L.E., Ingber D.E. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 2009, 457:1103-1108.
19. Dong Y., Xie X., Wang Z., Hu C., Zheng Q., Wang Y., Chen R., Xue T., Chen J., Gao D., Wu W., Ren Z., Cui J. Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin beta1. Biochem. Biophys. Res. Commun. 2014, 444:427-432.
20. Lopez J.I., Kang I., You W.K., McDonald D.M., Weaver V.M. In situ force mapping of mammary gland transformation. Integr. Biol. 2011, 3:910-921.
21. Chauhan V.P., Martin J.D., Liu H., Lacorre D.A., Jain S.R., Kozin S.V., Stylianopoulos T., Mousa A.S., Han X., Adstamongkonkul P., Popovic Z., Huang P., Bawendi M.G., Boucher Y., Jain R.K. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat. Commun. 2013, 4:2516.
22. Stylianopoulos T., Martin J.D., Chauhan V.P., Jain S.R., Diop-Frimpong B., Bardeesy N., Smith B.L., Ferrone C.R., Hornicek F.J., Boucher Y., Munn L.L., Jain R.K. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:15101-15108.
23. Stylianopoulos T., Martin J.D., Snuderl M., Mpekris F., Jain S.R., Jain R.K. Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res. 2013, 73:3833-3841.
24. Goel S., Duda D.G., Xu L., Munn L.L., Boucher Y., Fukumura D., Jain R.K. Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 2011, 91:1071-1121.
25. Burkholder B., Huang R.Y., Burgess R., Luo S., Jones V.S., Zhang W., Lv Z.Q., Gao C.Y., Wang B.L., Zhang Y.M., Huang R.P. Tumor-induced perturbations of cytokines and immune cell networks. Biochim. Biophys. Acta 2014, 1845:182-201.
26. Fridman W.H., Pages F., Sautes-Fridman C., Galon J. The immune contexture in human tumours: impact on clinical outcome, Nature reviews. Cancer 2012, 12:298-306.
27. Mamlouk S., Wielockx B. Hypoxia-inducible factors as key regulators of tumor inflammation, International journal of cancer. J. Int. Cancer 2013, 132:2721-2729.
28. Palazon A., Goldrath A.W., Nizet V., Johnson R.S. HIF transcription factors. Inflamm. Immun. Immun. 2014, 41:518-528.
29. O'Connor R.S., Hao X., Shen K., Bashour K., Akimova T., Hancock W.W., Kam L.C., Milone M.C. Substrate rigidity regulates human T cell activation and proliferation. J. Immunol. 2012, 189:1330-1339.
30. Patsialou A., Wyckoff J., Wang Y., Goswami S., Stanley E.R., Condeelis J.S. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res. 2009, 69:9498-9506.
31. Madar S., Goldstein I., Rotter V. 'Cancer associated fibroblasts'-more than meets the eye. Trends Mol. Med. 2013, 19:447-453.
32. Akiri G., Sabo E., Dafni H., Vadasz Z., Kartvelishvily Y., Gan N., Kessler O., Cohen T., Resnick M., Neeman M., Neufeld G. Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. Cancer Res. 2003, 63:1657-1666.
33. Pickup M.W., Laklai H., Acerbi I., Owens P., Gorska A.E., Chytil A., Aakre M., Weaver V.M., Moses H.L. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-beta-deficient mouse mammary carcinomas. Cancer Res. 2013, 73:5336-5346.
34. Lee H.O., Mullins S.R., Franco-Barraza J., Valianou M., Cukierman E., Cheng J.D. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer 2011, 11:245.
35. Ozdemir B.C., Pentcheva-Hoang T., Carstens J.L., Zheng X., Wu C.C., Simpson T.R., Laklai H., Sugimoto H., Kahlert C., Novitskiy S.V., De Jesus-Acosta A., Sharma P., Heidari P., Mahmood U., Chin L., Moses H.L., Weaver V.M., Maitra A., Allison J.P., LeBleu V.S., Kalluri R. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 2014, 25:719-734.
36. Srebrow A., Friedmann Y., Ravanpay A., Daniel C.W., Bissell M.J. Expression of Hoxa-1 and Hoxb-7 is regulated by extracellular matrix-dependent signals in mammary epithelial cells. J. Cell. Biochem. 1998, 69:377-391.
37. Brabletz T., Spaderna S., Kolb J., Hlubek F., Faller G., Bruns C.J., Jung A., Nentwich J., Duluc I., Domon-Dell C., Kirchner T., Freund J.N. Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression. Cancer Res. 2004, 64:6973-6977.
38. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nature reviews. Cancer 2002, 2:777-785.
39. Bhatlekar S., Fields J.Z., Boman B.M. HOX genes and their role in the development of human cancers. J. Mol. Med. 2014, 92:811-823.
40. Shah N., Sukumar S. The Hox genes and their roles in oncogenesis, Nature reviews. Cancer 2010, 10:361-371.
41. Gilbert P.M., Mouw J.K., Unger M.A., Lakins J.N., Gbegnon M.K., Clemmer V.B., Benezra M., Licht J.D., Boudreau N.J., Tsai K.K., Welm A.L., Feldman M.D., Weber B.L., Weaver V.M. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J. Clin. Invest. 2010, 120:1535-1550.
42. Ko S.Y., Barengo N., Ladanyi A., Lee J.S., Marini F., Lengyel E., Naora H. HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. J. Clin. Invest. 2012, 122:3603-3617.
43. Costa B.M., Smith J.S., Chen Y., Chen J., Phillips H.S., Aldape K.D., Zardo G., Nigro J., James C.D., Fridlyand J., Reis R.M., Costello J.F. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res. 2010, 70:453-462.
44. Ko S.Y., Ladanyi A., Lengyel E., Naora H. Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype. Am. J. Pathol. 2014, 184:271-281.
45. Bronsert P., Kohler I., Timme S., Kiefer S., Werner M., Schilling O., Vashist Y., Makowiec F., Brabletz T., Hopt U.T., Bausch D., Kulemann B., Keck T., Wellner U.F. Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer. Surgery 2014, 156:97-108.
46. Zhang P., Sun Y., Ma L. ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle 2015, 14(4):481-487.
47. Ren D., Wang M., Guo W., Huang S., Wang Z., Zhao X., Du H., Song L., Peng X. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Cell Tissue Res. 2014, 358:763-778.
48. Sha L., Dong L., Lv L., Bai L., Ji X. HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-beta1 pathway in hepatocellular carcinoma cells. Clin. Exp. Med. 2015, 15:55-64.
49. Yu M., Smolen G.A., Zhang J., Wittner B., Schott B.J., Brachtel E., Ramaswamy S., Maheswaran S., Haber D.A. A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. Genes Dev. 2009, 23:1737-1742.
50. Guo J., Fu Z., Wei J., Lu W., Feng J., Zhang S. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/beta-catenin pathway in gastric cancer. Med. Oncol. 2015, 32:393.
51. Micalizzi D.S., Christensen K.L., Jedlicka P., Coletta R.D., Baron A.E., Harrell J.C., Horwitz K.B., Billheimer D., Heichman K.A., Welm A.L., Schiemann W.P., Ford H.L. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. J. Clin. Invest. 2009, 119:2678-2690.
52. Holland P.W., Booth H.A., Bruford E.A. Classification and nomenclature of all human homeobox genes. BMC Biol. 2007, 5:47.
53. Mace K.A., Hansen S.L., Myers C., Young D.M., Boudreau N. HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J. Cell Sci. 2005, 118:2567-2577.
54. Cuevas I.C., Layman H.R., Coussens L.M., Boudreau N.J. Sustained endothelial expression of HoxA5 in vivo impairs pathological angiogenesis and tumor progression. PLoS One 2015, [in press].
55. Brock A., Krause S., Li H., Kowalski M., Goldberg M.S., Collins J.J., Ingber D.E. Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice. Sci. Transl. Med. 2014, 6:217ra212.
56. Morgan R., Boxall A., Harrington K.J., Simpson G.R., Michael A., Pandha H.S. Targeting HOX transcription factors in prostate cancer. BMC Urol. 2014, 14:17.
57. Morgan R., Boxall A., Harrington K.J., Simpson G.R., Gillett C., Michael A., Pandha H.S. Targeting the HOX/PBX dimer in breast cancer. Breast Cancer Res. Treat. 2012, 136:389-398.
58. Patrick A.N., Cabrera J.H., Smith A.L., Chen X.S., Ford H.L., Zhao R. Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome. Nat. Struct. Mol. Biol. 2013, 20:447-453.
59. Rhoads K., Arderiu G., Charboneau A., Hansen S.L., Hoffman W., Boudreau N. A role for Hox A5 in regulating angiogenesis and vascular patterning. Lymphat. Res. Biol. 2005, 3:240-252.
60. Carrio M., Arderiu G., Myers C., Boudreau N.J. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res. 2005, 65:7177-7185.